Objective: The presence of exogenous DNA in commercially available polymerase chain reaction (PCR) reagent preparations is a serious problem when amplifying conserved regions of bacteria. The preferred and currently in-use method of decontamination using 8-methoxypsoralen (8-MOP) and UVA requires re-standardization of decontamination with increasing concentrations of 8-MOP and UVA irradiation timings, if the DNA load of reagents is high due to lot-to-lot differences. The objective of this study was to develop a decontamination method, which would (i) work at the minimum reported concentration of 8-MOP and UVA irridation timings; and (ii) take care of inter-batch DNA-load variability of reagents.
Materials And Methods: The improved method described here was formulated after studying the exact molecular mechanism of action of 8-MOP with DNA. The successful working of the method was experimentally proven and validated with 6-7 new batches of PCR reagents. The sensitivity of eubacterial PCR, after using the new method of decontamination, to be used clinically was checked with both the spiked specimens and the actual clinical specimens.
Results And Discussion: The new method was found to work at the same starting parameters of 8-MOP and UVA in such situations. The increased efficiency of this method was found to be due to the synergistic effect of both the selective treatment of Taq DNA polymerase and the split-irradiation approach.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/BF03260072 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Application of Photodynamic Therapy with 5-Aminolevulinic Acid to Extracorporeal Photopheresis in the Treatment of Cutaneous T-Cell Lymphoma: A First-in-Human Phase I/II Study.
Pharmaceutics
June 2024
Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, 0310 Oslo, Norway.
Article Synopsis
- Extracorporeal photopheresis (ECP) is a treatment for T-cell-related disorders that involves using a drug (8-MOP) and UV light to kill T-cells, but it isn't very selective and can harm healthy cells.
- An alternative, ALA-based photodynamic therapy, shows more promise in targeting T-cells effectively without harming healthy cells, based on previous studies.
- A clinical trial with one cutaneous T-cell lymphoma patient found that ALA-ECP was safe, led to a significant reduction in skin symptoms, and resulted in only mild adverse events.
The effect of UVA light/8-methoxypsoralen exposure used in Extracorporeal Photopheresis treatment on platelets and extracellular vesicles.
PLoS One
March 2024
UCD Conway SPHERE Research Group, Conway Institute, University College Dublin, Dublin, Ireland.
Extracorporeal Photopheresis (ECP) is a leukapheresis based treatment for Cutaneous T-Cell Lymphoma, which takes advantage of the cellular lethal effects of UVA light in combination with a photoactivated drug, 8-methoxypsoralen. 25% of patients treated with ECP do not respond to treatment, however the underlying mechanisms for this lack of response remain unknown. Platelets, a rich source of extracellular vesicles (EVs) and key mediators in thromboinflammatory oncological progression, as well as leukocytes, are both processed through ECP and are subsequently transfused back into the patient, delivering potent immunomodulation.
View Article and Find Full Text PDFEvaluation of the Cellular Resistance Process in Treated Cells Via Extracorporeal Photopheresis.
J Lasers Med Sci
October 2023
Department of surgery, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Extracorporeal photopheresis (ECP) is a therapeutic method applied against some diseases such as cancers. Using 8-methoxypsoralen (8-MOP) and UVA radiation in ECP is associated with achievement in the treatment of patients with leukemic cutaneous T-cell lymphoma (CTCL). Evaluation of cellular resistance versus ECP is the aim of this study.
View Article and Find Full Text PDFBath-psoralen plus UVA therapy changes inflammatory proteomic signatures for systemic effects beyond the skin.
J Dermatol Sci
December 2023
Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan. Electronic address:
Furocoumarins potentiate UVA-induced DNA damage in skin melanocytes.
Biochem Biophys Res Commun
December 2023
Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, RI, USA; Department of Epidemiology, Brown University School of Public Health, Providence, RI, USA; Channing Division of Network Medicine, Department of Medicine Research, Brigham and Women's Hospital, Boston, MA, USA. Electronic address:
Epidemiological studies have found that high citrus fruit consumption was associated with higher risk of skin cancer. Citrus fruits and some vegetables contain furocoumarins, which may interact with ultraviolet radiation to induce skin cancer. We aimed to determine the effects of two furocoumarins, including 8-methoxypsoralen (8-MOP) and 6',7'-dihydroxybergamottin (DHB), on UVA-induced DNA damage in human epidermal melanocytes, the origin of melanoma.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!